Kratia Pharmaceuticals Showcases Advancements at the 33rd Japanese Gastroenterology Week
Kratia Pharmaceuticals, renowned for its commitment to Kampo medicine, is set to make a significant presence at the upcoming
33rd Japanese Gastroenterology Week, which will take place from
October 30 to November 1, 2025, at the
Kobe Convention Center. This event, sponsored by the
Japanese Society of Gastroenterology, is a pivotal gathering of medical professionals, including doctors, nurses, pharmacists, clinical laboratory technicians, and researchers.
This year marks a special milestone as Kratia will
debut the KB2 Stick, a twice-daily oral Kampo formulation, aiming to raise awareness about its benefits and usage. Initially launched by Kratia in
2002, the KB2 Stick has been tailored to meet the evolving needs of modern patients who seek convenience in managing their health.
Since the launch of its medical Kampo extract formulations in
1981, Kratia Pharmaceuticals has focused on developing treatment options that resonate with individual patient needs. The KB2 Stick exemplifies this dedication, providing an innovative solution for patients looking to reduce their daily medication doses and avoid forgetting doses during busy daytime schedules. The compact design, featuring a small mouth opening, makes it easy to take on the go, perfectly suited for today’s dynamic lifestyles.
During the event, Kratia will showcase the evolution of Kampo formulations, featuring a range of exhibitions:
1.
Panel Displays: Presenting the journey of Kratia’s Kampo products, the operational aspects of its manufacturing sites, and the safety measures like pesticide residue management.
2.
Educational Resources for Medical Professionals: Providing vital information and insights relevant to current Kampo practices.
3.
Pediatric Medication Support Product: An exhibit of the 'Oku-Suri Pakuttone Ru-Ru', a product designed to assist children with medication intake, will also be featured. Attendees who complete a survey will have the chance to receive this educational material.
Understanding Kratia's Medical Kampo Products
Kratia Pharmaceuticals has been a pioneer in offering Kampo medicine—a traditional Japanese herbal practice—by transitioning these remedies from traditional decoction methods to more accessible extract formulations. This transformation ensures patients can enjoy the benefits of Kampo without the complexities of preparation traditionally associated with these remedies.
In response to feedback from patients asking for increased convenience, Kratia became the first to introduce a twice-daily dosage option with the KB2 Stick. By packaging these formulations in portable stick forms, Kratia is addressing the growing need for adaptability in health management. The KB2 Stick not only caters to patients compelled by busy lifestyles but also underscores Kratia’s commitment to continuously improve accessibility to traditional medicine.
Kratia Pharmaceuticals prides itself on being a professional hub in the realm of Kampo medicines, extending its offerings from general pharmaceuticals to specialized medical products. In the rapidly evolving health landscape, the company is enhancing the synergy between its medical and general health sectors, reinforcing its brand as the unified advocate for health through Kampo.
The Future of Kampo Medicine
As Kratia Pharmaceuticals looks ahead, the company remains focused on the vital role of Kampo in promoting comprehensive health. Their mission is to empower individuals in Japan to take a holistic approach to their health by utilizing Kampo medicine. They endeavor to support the creation of healthier lifestyles through their diverse product offerings, ensuring that the essence of traditional medicine is preserved while adapting to contemporary needs.
Kratia invites all medical practitioners and interested parties to visit their booth to learn more about their pioneering innovations and contributions to the world of Kampo medicine. Don't miss this opportunity to engage with experienced professionals and discover the transformative potential of Kampo formulations.